Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT01637220
Eligibility Criteria:
Selection of cases :
INCLUSION CRITERIA:
* Any patient of age 18 and over:
* Presenting with clinical signs compatible with a perioperative anaphylactic reaction to neuromuscular blocking drugs, whatever the grade of the anaphylactic reaction
* That was treated following the French Patient Management 2011 guidelines
EXCLUSION CRITERIA:
\- pregnant women
Selection of controls:
INCLUSION CRITERIA :
* Any patient of age 18 and over
* Hospitalized for a surgical intervention necessitating a neuromuscular blocking drug injection, without developing an anaphylactic reaction
* That had been informed of the particulars of the study and that had consented to participate in this study
EXCLUSION CRITERIA: none
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01637220
Study Brief:
Protocol Section:
NCT01637220